NCT05635370View on ClinicalTrials.gov

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Pentoxifylline Versus Cilostazol

CompletedOBSERVATIONAL
Enrollment

10,398

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

July 7, 2023

Study Completion Date

December 31, 2023

Conditions
Peripheral Artery Disease
Interventions
DRUG

Pentoxifylline

Pentoxifylline claim is used as the exposure group.

DRUG

Cilostazol

Cilostazol claim is used as the reference group.

Trial Locations (1)

02120

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

collaborator

Rutgers University

OTHER

collaborator

Johns Hopkins University

OTHER

lead

Brigham and Women's Hospital

OTHER